Pivotal Trial of Automated Artificial Intelligence (AI) Based System for Early Diagnosis of Diabetic Retinopathy

Launched by IHEALTHSCREEN INC ·

Keywords

ClinConnect Summary

This clinical trial is testing a new computer program called iPredict-DR that uses artificial intelligence (AI) to help find early signs of diabetic retinopathy, a common eye problem caused by diabetes that can lead to blindness if not caught early. The goal is to see how well this AI tool works when used in regular doctor’s offices and diabetes clinics, making it easier, faster, and less expensive to screen for eye problems without always needing a specialist.

People with diabetes who are interested in joining and are between 8 and 35 years old may be eligible to take part. If you join, the AI system will analyze images of your eyes during your regular clinic visit to check for signs of diabetic retinopathy. This could help catch the problem sooner and allow for quicker treatment. The study is currently looking for participants, and it hopes to make eye screenings more accessible, especially in places where eye doctors are hard to find.

Gender

ALL

Eligibility criteria